Add to ORKGThe article demonstrates the results of the clinical efficiency and tolerance of different antiviral therapy schemes (interferon, lamivudin and their combination) among children with chronic hepatitis b. the comparative research involved 85 children, who underwent the examination of the biochemical blood analysis, hepatitis b markers (Elisa, PCR), histological study of the liver tissues.Key words: children, chronic hepatitis b, interferon, lamivudin
Abstract- Hepatitis C virus infection has reached epidemic proportions worldwide and there is increa...
A meta-analysis of six randomized clinical trials involving 240 children with chronic hepatitis B tr...
Hepatitis B virus (HBV) infection may cause acute, fulminant , or chronic hepatitis, leading to live...
The article demonstrates the results of the clinical efficiency and tolerance of different antiviral...
In pediatrics, the issue of using antivirus therapy for chronic virus hepatitis is not sufficiently ...
Chronic hepatitis B virus infection acquired perinatally or during the first years of life is usuall...
Children with chronic hepatitis B, face life long disease and complications of cirrhosis and hepatoc...
Treatment of chronic hepatitis B with interferon alfa is not approved in children. The aim of this s...
logical and histological responses in chronic hepatitis B (CHB)-infected children who received combi...
WOS: 000177028800012PubMed ID: 12139566Background : Lamivudine is a new alternative therapeutic agen...
Despite of extensive blood product screening and national immunization programs, chronic hepatitis B...
Background and Aim: The aim of the present study was to compare the therapeutic efficacy of three di...
<em>The article describes an efficacy of interferon alpha-2a (Roferon-A) in 69 children with chronic...
Children with chronic hepatitis B are at risk of developing long-term complications such as cirrhosi...
WOS: 000177749200008PubMed ID: 12201869Background and Aim: To compare the therapeutic efficacy of tw...
Abstract- Hepatitis C virus infection has reached epidemic proportions worldwide and there is increa...
A meta-analysis of six randomized clinical trials involving 240 children with chronic hepatitis B tr...
Hepatitis B virus (HBV) infection may cause acute, fulminant , or chronic hepatitis, leading to live...
The article demonstrates the results of the clinical efficiency and tolerance of different antiviral...
In pediatrics, the issue of using antivirus therapy for chronic virus hepatitis is not sufficiently ...
Chronic hepatitis B virus infection acquired perinatally or during the first years of life is usuall...
Children with chronic hepatitis B, face life long disease and complications of cirrhosis and hepatoc...
Treatment of chronic hepatitis B with interferon alfa is not approved in children. The aim of this s...
logical and histological responses in chronic hepatitis B (CHB)-infected children who received combi...
WOS: 000177028800012PubMed ID: 12139566Background : Lamivudine is a new alternative therapeutic agen...
Despite of extensive blood product screening and national immunization programs, chronic hepatitis B...
Background and Aim: The aim of the present study was to compare the therapeutic efficacy of three di...
<em>The article describes an efficacy of interferon alpha-2a (Roferon-A) in 69 children with chronic...
Children with chronic hepatitis B are at risk of developing long-term complications such as cirrhosi...
WOS: 000177749200008PubMed ID: 12201869Background and Aim: To compare the therapeutic efficacy of tw...
Abstract- Hepatitis C virus infection has reached epidemic proportions worldwide and there is increa...
A meta-analysis of six randomized clinical trials involving 240 children with chronic hepatitis B tr...
Hepatitis B virus (HBV) infection may cause acute, fulminant , or chronic hepatitis, leading to live...